Immunotherapy has transformed the foundation of cancer care, and according to the American Association for Cancer Research, it’s one of the 5 pillars of cancer treatment. How much do you know about immunotherapy? Test your knowledge here.
References
- Hodi FS, O’Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711-723. doi:10.1056/NEJMoa1003466
- Reck M, Rodríguez-Abreu D, Robinson AG, et al. Pembrolizumab versus chemotherapy for PD-L1–positive non–small-cell lung cancer. N Engl J Med. 2016;375:1823-1833. doi:10.1056/NEJMoa1606774
- Halim L, Maher J. CAR T-cell immunotherapy of B-cell malignancy: the story so far. Ther Adv Vaccines Immunother. 2020;8:2515135520927164. doi:10.1177/2515135520927164
- Underwood PW, Ruff SM, Pawlik TM. Update on targeted therapy and immunotherapy for metastatic colorectal cancer. Cells. 2024;13:245. doi:10.3390/cells13030245
- Zhou S, Liu M, Ren F, et al. The landscape of bispecific T cell engager in cancer treatment. Biomark Res. 2021;9:38. doi:10.1186/s40364-021-00294-9